aceRNA Technologies Co., Ltd. is a biotech startup established in 2018 based on RNA design technology developed in synthetic RNA biology research by Prof. Hirohide Saito at Kyoto University. We are developing "smart gene therapy” (mRNA-based and virus-base) that enables control of therapeutic transgene expression in cell-type and -state specific manner. By that, we are committed to develop new therapeutic approach, such as in vivo cell programming.
Company Details
- Employees
- 9
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://acernatec.com/en/
Acerna Technologies Questions
Acerna Technologies's website is https://acernatec.com/en/
Acerna Technologies's LinkedIn profile is https://www.linkedin.com/company/acerna-technologies
Acerna Technologies has
9 employees.
View email and phone details for 9
employees at Acerna Technologies.
Acerna Technologies's industry is
Biotechnology Research
Acerna Technologies's top competitors are
Eleven Therapeutics,
Anviron,
Interface Biosciences,
Vian Therapeutics,
Strand Therapeutics,
Arthex Biotech,
Acrobat Genomics,
Biorchestra Co., Ltd.,
Engage Bio,
Therabest.
Acerna Technologies's categories are Biotechnology Research
